Omeros claims a failed drug study was ‘positive.’ Investors were not fooled
A biotech claimed to have “positive” clinical trial results. The results were, well, not.
by Adam Feuerstein
Oct 01, 2018
1 minute
During our last week, I warned investors to be wary of biotechs that claim to have “positive” clinical trial results in the headline of their press
You’re reading a preview, subscribe to read more.
Start your free 30 days